Published in J Infect Dis on August 01, 1995
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun (1999) 1.54
A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa. Infect Immun (2009) 1.12
A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect Immun (1998) 1.02
Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population. Thorax (2006) 0.90
Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects. Infect Immun (2006) 0.88
Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients. J Infect Dis (1996) 0.75
Cystic fibrosis therapy--where we are and how we got there. West J Med (1996) 0.75
Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res (2000) 7.29
Cystic fibrosis. Am J Respir Crit Care Med (1996) 4.56
Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet (1990) 4.39
Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. J Neurosurg (1989) 4.18
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
Attainment and adjustment in two geographical areas. I--The prevalence of psychiatric disorder. Br J Psychiatry (1975) 3.79
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis (1985) 3.71
Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation (1990) 3.52
Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations. Diabetes Care (1991) 3.51
Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol (1985) 3.50
Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med (1995) 3.47
Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med (1994) 3.24
Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet (1993) 3.17
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04
Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. J Infect Dis (1979) 3.02
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest (1984) 2.88
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr (2001) 2.78
c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem (2000) 2.71
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J (1999) 2.64
Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care (1987) 2.50
Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. J Infect Dis (1983) 2.41
Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36
Pneumothorax in cystic fibrosis: a 26-year experience. Ann Thorac Surg (1989) 2.23
Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia (1983) 2.18
The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol (2001) 2.18
Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis (1986) 2.10
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest (1997) 2.10
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol (1999) 2.05
Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med (1976) 2.04
Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis (1985) 2.04
Sleep and depression--results from psychobiological studies: an overview. Biol Psychol (2001) 2.02
Effect of age on excess mortality in obesity. JAMA (1999) 2.01
Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia (1997) 1.95
Oxidative damage to DNA: formation, measurement, and biological significance. Rev Physiol Biochem Pharmacol (1997) 1.91
Glucose metabolism in perfused skeletal muscle. Effects of starvation, diabetes, fatty acids, acetoacetate, insulin and exercise on glucose uptake and disposition. Biochem J (1976) 1.90
The formation of glutamine and alanine in skeletal muscle. J Biol Chem (1974) 1.90
Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia (1987) 1.87
Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia (1990) 1.84
Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol (1995) 1.82
Regulation of glucose and ketone-body metabolism in brain of anaesthetized rats. Biochem J (1974) 1.78
Course of cystic fibrosis in 95 patients. J Pediatr (1976) 1.78
Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol (1998) 1.73
Identifying treatments that halt progression of pulmonary disease in cystic fibrosis. Pediatr Res (1997) 1.72
Glucose metabolism in perfused skeletal muscle. Interaction of insulin and exercise on glucose uptake. Biochem J (1975) 1.71
Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol (1997) 1.68
Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous, and intravenous administration. Diabetes Care (1985) 1.67
Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia (1993) 1.67
Issues in the measurement of satisfaction with treatment. Am J Manag Care (1997) 1.67
Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest (1990) 1.66
A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin Infect Dis (1999) 1.64
Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J Cell Biol (1998) 1.63
Assessment of excess mortality in obesity. Am J Epidemiol (1998) 1.62
Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr (1994) 1.61
Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci (1993) 1.61
Glucose metabolism in rat skeletal muscle at rest. Effect of starvation, diabetes, ketone bodies and free fatty acids. Diabetes (1974) 1.61
Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med (1999) 1.59
Lack of binding of human C3, in its native state, to C3b receptors. J Immunol (1981) 1.57
Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet (1988) 1.56
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis. J Pediatr (2001) 1.56
The effect of early diagnosis and treatment in cystic fibrosis: a seven-year study of 16 sibling pairs. Am J Dis Child (1977) 1.55
Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study. J Pediatr (1989) 1.53
Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med (2000) 1.52
The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol (1997) 1.52
Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun (1983) 1.51
Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand (1994) 1.51
Uncontrolled-rate freezing and storage at -80 degrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion (2001) 1.51
Noninvasive estimation of pulmonary artery diastolic pressure in patients with tricuspid regurgitation by Doppler echocardiography. Chest (1999) 1.51
Action profiles of fast onset insulin analogues. Diabetologia (1990) 1.50
Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency. Lancet (1975) 1.50
Obstructive sleep apnea is a risk factor for difficult endotracheal intubation. Minerva Anestesiol (2011) 1.49
Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood (1997) 1.48
Unsuspected cardiac abnormalities in the acquired immune deficiency syndrome. An echocardiographic study. Chest (1989) 1.48
Echocardiographic detection of transient right heart thrombus: now you see it, now you don't. Am Heart J (1991) 1.48
Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies. J Immunol (1988) 1.48
Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. J Pediatr (1984) 1.47
Test-retest reliability and validity of the Structured Interview for Sleep Disorders According to DSM-III-R. Am J Psychiatry (1993) 1.46
Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs. J Pediatr (1978) 1.45
Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS. J Infect Dis (1988) 1.45
Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest (1988) 1.42
Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease. Diabetologia (1997) 1.42
Captopril, blood pressure, and diabetic nephropathy. JAMA (1994) 1.42
[Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities]. Nervenarzt (1996) 1.42
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci (1997) 1.41
Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin. Diabet Med (1996) 1.41
Hemodialysis of children: a review. Tex Med (1976) 1.40
[The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?]. Dtsch Med Wochenschr (1992) 1.39
Diabetes care in cats and dogs. Diabet Med (2002) 1.39
[Significance of historical and current hallucinogenic research in psychiatry]. Nervenarzt (1993) 1.39
[Differential indications for psychotherapy exemplified by depression]. Nervenarzt (2011) 1.39
Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med (1992) 1.38
Pulmonary intralobar sequestration in a patient with cystic fibrosis. Hum Pathol (1997) 1.38
HLA-DR2 and sleep onset REM periods in endogenous depression. Br J Psychiatry (1988) 1.38
Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol (1999) 1.38